Hundemer Gregory L, Baudrand Rene, Brown Jenifer M, Curhan Gary, Williams Gordon H, Vaidya Anand
Division of Renal Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts 02115.
Program for Adrenal Disorders and Endocrine Hypertension, Department of Endocrinology, Pontificia Universidad Catolica de Chile School of Medicine, Santiago, Chile.
J Clin Endocrinol Metab. 2017 Jun 1;102(6):1835-1843. doi: 10.1210/jc.2016-3867.
Mild cases of autonomous aldosterone secretion may go unrecognized using current diagnostic criteria for primary aldosteronism (PA).
To investigate whether the inability to stimulate renin serves as a biomarker for unrecognized autonomous aldosterone secretion and mineralocorticoid receptor (MR) activation.
Six hundred sixty-three normotensive and mildly hypertensive participants, who were confirmed to not have PA using current guideline criteria and were on no antihypertensive medications.
Participants had their maximally stimulated plasma renin activity (PRA) measured while standing upright after sodium restriction. Tertiles of maximally stimulated PRA were hypothesized to reflect the degree of MR activation: lowest PRA tertile = "Inappropriate/Excess MR Activity;" middle PRA tertile = "Intermediate MR Activity;"; and highest PRA tertile = "Physiologic MR Activity." All participants underwent detailed biochemical and vascular characterizations under conditions of liberalized sodium intake, and associations with stimulated PRA phenotypes were performed.
Participants with lower stimulated PRA had greater autonomous aldosterone secretion [higher aldosterone-to-renin ratio (P = 0.002), higher urine aldosterone excretion rate (P = 0.003), higher systolic blood pressure (P = 0.004), and lower renal plasma flow (P = 0.04)] and a nonsignificant trend toward lower serum potassium and higher urine potassium excretion, which became significant after stratification by hypertension status.
In participants without clinical PA, the inability to stimulate renin was associated with greater autonomous aldosterone secretion, impaired vascular function, and suggestive trends in potassium handling that indicate an extensive spectrum of unrecognized MR activation.
根据目前原发性醛固酮增多症(PA)的诊断标准,轻度自主性醛固酮分泌病例可能未被识别。
研究无法刺激肾素是否可作为未被识别的自主性醛固酮分泌和盐皮质激素受体(MR)激活的生物标志物。
663名血压正常和轻度高血压参与者,他们根据当前指南标准被确认没有PA,且未服用抗高血压药物。
参与者在限钠后直立位时测量其最大刺激血浆肾素活性(PRA)。假设最大刺激PRA的三分位数反映MR激活程度:最低PRA三分位数 = “不适当/过度MR活性”;中间PRA三分位数 = “中等MR活性”;最高PRA三分位数 = “生理性MR活性”。所有参与者在钠摄入放宽的条件下进行详细的生化和血管特征分析,并与刺激后的PRA表型进行关联分析。
刺激后PRA较低的参与者具有更高的自主性醛固酮分泌[醛固酮与肾素比值更高(P = 0.002)、尿醛固酮排泄率更高(P = 0.003)、收缩压更高(P = 0.004)以及肾血浆流量更低(P = 0.04)],并且血清钾降低和尿钾排泄增加的趋势不显著,在按高血压状态分层后变得显著。
在无临床PA的参与者中,无法刺激肾素与更高的自主性醛固酮分泌有关,血管功能受损,以及钾处理方面的提示性趋势,这表明存在广泛的未被识别的MR激活。